ΔΎΉΟΦ±²₯

Oncology/Hematology

News, opinions and meeting coverage in oncology/hematology.

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

β€” Almost half of patients in active surveillance avoided cystectomy during 40 months of follow-up

A computer rendering of a transparent body with a bladder tumor highlighted.

Latest in Oncology/Hematology

Congress Ditched Fix to Medicare Doc Pay Cut in Skinny Budget Bill

One warns of "dangerous game" in continuing Medicare pay cuts

4 Hrs Ago
Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

Study paves the way for quadruple therapy in patients not eligible for a stem cell transplant

4 Hrs Ago
New BCMA-Directed Therapies Show Promise in Multiple Myeloma

Reduced toxicity and improved convenience position new treatments for broader use

5 Hrs Ago
Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

Rapid evaluation and novel therapies may improve outcomes for these patients

5 Hrs Ago
New BCMA-Directed Therapies Show Promise in Multiple Myeloma

Reduced toxicity and improved convenience position new treatments for broader use

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

Rapid evaluation and novel therapies may improve outcomes for these patients

Oncology/Hematology Case Studies

Middle-Age Man Presents With Necrotizing Mass on Nose

Rare condition can be deadly without early diagnosis and treatment

 A photo through the doorway of the CT scanning room.
Significant Left Nasal Obstruction Finally Diagnosed After 2 Years

Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man

A female ear, nose, and throat doctor wearing a headlamp examines her senior male patient.
After Chemo, Breast Cancer Patient Develops Two Malignant Neoplasms

Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge

A photo of a woman’s hand on her skin, which is affected by a rash.

More in Oncology/Hematology

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

Ponatinib-blinatumomab led to durable remissions without transplant in most, but 13% relapsed

5 Hrs Ago
image
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

Meta-analysis shows inverse dose-response relationship for both beverages

Dec 23, 2024
A photo of a man holding a cardboard container of four to-go cups of coffee.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries

Also in TTHealthWatch: electronic nudges for flu shots

Dec 21, 2024
TTUHSC EL PASO HEALTHWATCH with their logo and photos of Rick Lange, MD, and Elizabeth Tracey
No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

News, features, and commentary about cancer-related issues

Dec 20, 2024
Onco Break over a computer rendering of a cancer cell.
Sticking With CDK4/6 Inhibitors for Breast Cancer Wins in Post-Progression Setting

Lack of biomarkers handicaps decision making in era of expanding treatment options

Dec 20, 2024
A computer rendering of breast cancer.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

Newest EGFR TKIs have changed the game for treating asymptomatic brain metastases

Dec 20, 2024
A computer rendering of a transparent head with brain metastases highlighted.
Randy Moss' Rare GI Cancer: Here's What to Know

Hall of Fame football player recently revealed his cholangiocarcinoma diagnosis

Dec 20, 2024
 A photo of Randy Moss.
Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma

Experts at ASH debate quadruplet therapy, dexamethasone modulation, and novel approaches

Dec 20, 2024
image
Health of Myeloma Patient's Marriage Tied to Recovery After Transplant

Study links strong relationships to better physical and emotional outcomes in myeloma care

Dec 20, 2024
image
Optimizing Sequencing of BCMA-Directed Therapies in Myeloma

Longer gaps between anti-BCMA agents associated with improved response rates, study finds

Dec 20, 2024
image
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

Experts talk about long-term data and the importance of infection prophylaxis

Dec 19, 2024
image
FDA Approves Mesenchymal Stromal Cell Therapy for Refractory Acute GVHD in Kids

Response rate of 70% at day 28 with remestemcel-L

Dec 19, 2024
FDA APPROVED remestemcel-L (Ryoncil) over a photo of a bag of stem cells in a purple rubber-gloved hand.
New First-Line Option for Advanced ALK-Positive Lung Cancer

In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor

Dec 18, 2024
FDA APPROVED ensartinib (Ensacove) over a computer rendering of lung cancer.
Opinion
What Comes After Cancer?

Alarming mental health challenges among young cancer survivors, especially males, demand action

Dec 17, 2024
A photo of a young man discussing his chemotherapy treatment with his male doctor.
More in Oncology/Hematology

Latest Meetings